2024 annual financial data
Arcturus Therapeutics Holdings 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -43.17%.
Operating income was -95,669,000 USD and net income was -80,941,000 USD.
Operating cash flow was -59,747,000 USD.
Get free Arcturus Therapeutics Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 138,389,000 USD
- Operating income
- -95,669,000 USD
- Net income
- -80,941,000 USD
- Operating cash flow
- -59,747,000 USD